BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea
· Delayed Price · Currency is KRW
5,640.00
-10.00 (-0.18%)
At close: Aug 13, 2025, 3:30 PM KST
BioInfra Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Aug '25 Aug 15, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 27,095 | 31,132 | 58,090 | - | - | - | |
Market Cap Growth | -42.35% | -46.41% | - | - | - | - | |
Enterprise Value | 26,870 | 29,976 | 49,551 | - | - | - | |
Last Close Price | 5570.00 | 6400.00 | 11362.47 | - | - | - | |
PE Ratio | - | - | 29.02 | - | - | - | |
PS Ratio | 1.12 | 1.31 | 1.93 | - | - | - | |
PB Ratio | 1.13 | 1.13 | 1.71 | - | - | - | |
P/TBV Ratio | 1.19 | 1.18 | 1.77 | - | - | - | |
P/OCF Ratio | - | 18.00 | 85.51 | - | - | - | |
EV/Sales Ratio | 1.11 | 1.26 | 1.65 | - | - | - | |
EV/EBITDA Ratio | - | - | 13.42 | - | - | - | |
EV/EBIT Ratio | - | - | 37.96 | - | - | - | |
Debt / Equity Ratio | 0.45 | 0.31 | 0.27 | 0.47 | 1.38 | 1.78 | |
Debt / EBITDA Ratio | - | - | 2.43 | 1.02 | 1.74 | 1.68 | |
Debt / FCF Ratio | - | - | - | - | - | 4.04 | |
Asset Turnover | 0.55 | 0.54 | 0.76 | 1.07 | 1.19 | 1.45 | |
Quick Ratio | 1.03 | 1.43 | 2.10 | 1.69 | 0.93 | 0.71 | |
Current Ratio | 1.16 | 1.60 | 2.52 | 2.02 | 1.17 | 0.82 | |
Return on Equity (ROE) | -15.76% | -12.92% | 7.72% | 43.36% | 82.12% | 227.53% | |
Return on Assets (ROA) | -8.28% | -7.26% | 2.05% | 11.99% | 18.22% | 16.71% | |
Return on Capital (ROIC) | -9.89% | -8.08% | 2.35% | 15.21% | 24.62% | 27.71% | |
Return on Capital Employed (ROCE) | - | - | 3.40% | 24.30% | 33.00% | 61.30% | |
Earnings Yield | -15.63% | -12.77% | 3.45% | - | - | - | |
FCF Yield | -18.65% | -3.44% | -4.12% | - | - | - | |
Buyback Yield / Dilution | -1.31% | -3.17% | -13.83% | 0.02% | -200.05% | 0.01% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.